Taiwannews

Published September 22, 2026

Optimi Health Appoints Dr. Michael Blough as Chief Clinical Development Officer - Taiwan News

Read the full story at Taiwannews

Supports Optimi's planned Phase 2 psilocybin trial in major depressive disorder and Phase 3 MDMA trial in PTSD. VANCOUVER, British Columbia, Sept.